HSILMedical Equipment & Supplies

HSIL LimitedCash Flow Statement

217.50
-5.96%

HSIL Limited Cash Flow Statement (Annual)

Metric20252024202320222021
Free Cash Flow-28.73 Cr-13.08 Cr2.37 Cr11.64 Cr
Issuance Of Capital Stock0.0021.70 Cr2.80 Cr0.00
Capital Expenditure-37.57 Cr-5.52 Cr-3.93 Cr-0.42 Cr
End Cash Position9.55 Cr13.17 Cr8.46 Cr5.83 Cr
Other Cash Adjustment Outside Changein Cash-1000.001000.001000.00-1000.00
Beginning Cash Position13.34 Cr8.46 Cr5.83 Cr1.52 Cr
Changes In Cash-3.79 Cr4.71 Cr2.63 Cr4.31 Cr
Financing Cash Flow17.64 Cr21.24 Cr-0.70 Cr-7.70 Cr
Interest Paid Cff-2.15 Cr-0.94 Cr-1.91 Cr-1.64 Cr
Net Common Stock Issuance0.0021.70 Cr2.80 Cr-1.25 Cr
Common Stock Issuance0.0021.70 Cr2.80 Cr0.00
Net Issuance Payments Of Debt19.79 Cr0.48 Cr-1.59 Cr-4.85 Cr
Net Long Term Debt Issuance19.79 Cr0.48 Cr-1.59 Cr-6.24 Cr
Investing Cash Flow-30.28 Cr-8.97 Cr-2.97 Cr-0.05 Cr
Net Other Investing Changes0.99 Cr
Interest Received Cfi0.59 Cr1.12 Cr0.50 Cr0.12 Cr
Net Investment Purchase And Sale3.47 Cr-4.57 Cr0.46 Cr0.24 Cr
Net PPE Purchase And Sale-35.33 Cr-5.52 Cr-3.93 Cr-0.42 Cr
Sale Of PPE2.24 Cr
Purchase Of PPE-37.57 Cr-2.45 Cr-0.42 Cr-2.39 Cr
Operating Cash Flow8.84 Cr-7.56 Cr6.30 Cr12.06 Cr
Taxes Refund Paid-1.93 Cr-3.22 Cr-2.53 Cr-0.35 Cr
Change In Working Capital-3.67 Cr-17.96 Cr-4.98 Cr4.04 Cr
Change In Other Current Liabilities4.39 Cr0.06 Cr-2.68 Cr3.83 Cr
Change In Other Current Assets-5.14 Cr-1.71 Cr-0.24 Cr1.42 Cr
Change In Payable14.36 Cr0.42 Cr3.06 Cr8.00 Cr
Change In Inventory-21.44 Cr-6.24 Cr-1.96 Cr1.99 Cr
Change In Receivables3.88 Cr-10.20 Cr-3.93 Cr-11.38 Cr
Other Non Cash Items2.72 Cr-0.18 Cr2.91 Cr1.52 Cr
Depreciation And Amortization1.43 Cr1.03 Cr0.85 Cr0.75 Cr
Depreciation1.43 Cr1.03 Cr0.85 Cr0.75 Cr
Gain Loss On Sale Of PPE-0.18 Cr-0.01 Cr0.000.00
Net Income From Continuing Operations10.47 Cr12.78 Cr10.06 Cr6.11 Cr
Net Other Financing Charges-1000.000.04 Cr1.30 Cr
Net Short Term Debt Issuance-4.31 Cr1.39 Cr-1.79 Cr
Sale Of Investment0.46 Cr0.36 Cr0.00
Purchase Of Investment-0.10 Cr-0.12 Cr-0.10 Cr
Repurchase Of Capital Stock-1.25 Cr
Common Stock Payments-1.25 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.